These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2539369

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparison of parathyroid hormone receptors in rat osteosarcoma cells and kidney.
    Kaufmann M, Fischer JA, Muff R.
    Biochim Biophys Acta; 1993 Nov 07; 1179(2):197-202. PubMed ID: 8218361
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Characterization and agonist-induced down-regulation of parathyroid hormone receptors in clonal rat osteosarcoma cells.
    Yamamoto I, Shigeno C, Potts JT, Segre GV.
    Endocrinology; 1988 Apr 07; 122(4):1208-17. PubMed ID: 2831022
    [Abstract] [Full Text] [Related]

  • 28. Effects of dietary-induced hyperparathyroidism on the parathyroid hormone-receptor-adenylate cyclase system of canine kidney. Evidence for postreceptor mechanism of desensitization.
    Tamayo J, Bellorin-Font E, Martin KJ.
    J Clin Invest; 1983 Aug 07; 72(2):422-32. PubMed ID: 6308054
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Quantitative evaluation of anticalciuretic effects of synthetic parathyroid hormonelike peptides.
    Scheinman SJ, Mitnick ME, Stewart AF.
    J Bone Miner Res; 1990 Jun 07; 5(6):653-8. PubMed ID: 2166424
    [Abstract] [Full Text] [Related]

  • 32. Parathyroid hormone receptors of renal cortex: specific binding of biologically active, 125I-labeled hormone and relationship to adenylate cyclase activation.
    Di Bella FP, Dousa TP, Miller SS, Arnaud CD.
    Proc Natl Acad Sci U S A; 1974 Mar 07; 71(3):723-6. PubMed ID: 4362630
    [Abstract] [Full Text] [Related]

  • 33. Canine renal receptors for parathyroid hormone. Down-regulation in vivo by exogenous parathyroid hormone.
    Mahoney CA, Nissenson RA.
    J Clin Invest; 1983 Aug 07; 72(2):411-21. PubMed ID: 6308053
    [Abstract] [Full Text] [Related]

  • 34. Photoaffinity labeling of the canine renal receptor for parathyroid hormone.
    Draper MW, Nissenson RA, Winer J, Ramachandran J, Arnaud CD.
    J Biol Chem; 1982 Apr 10; 257(7):3714-8. PubMed ID: 6277947
    [Abstract] [Full Text] [Related]

  • 35. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34).
    Jüppner H, Schipani E, Bringhurst FR, McClure I, Keutmann HT, Potts JT, Kronenberg HM, Abou-Samra AB, Segre GV, Gardella TJ.
    Endocrinology; 1994 Feb 10; 134(2):879-84. PubMed ID: 8299582
    [Abstract] [Full Text] [Related]

  • 36. A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2.
    Goldman ME, McKee RL, Caulfield MP, Reagan JE, Levy JJ, Gay CT, DeHaven PA, Rosenblatt M, Chorev M.
    Endocrinology; 1988 Nov 10; 123(5):2597-9. PubMed ID: 2844517
    [Abstract] [Full Text] [Related]

  • 37. Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH-(1-84).
    Inomata N, Akiyama M, Kubota N, Jüppner H.
    Endocrinology; 1995 Nov 10; 136(11):4732-40. PubMed ID: 7588200
    [Abstract] [Full Text] [Related]

  • 38. Analysis of the requirements for parathyroid hormone action in renal membranes with the use of inhibiting analogues.
    Goltzman D, Peytremann A, Callahan E, Tregear GW, Potts JT.
    J Biol Chem; 1975 Apr 25; 250(8):3199-203. PubMed ID: 164462
    [Abstract] [Full Text] [Related]

  • 39. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
    Merryman JI, Rosol TJ, Brooks CL, Capen CC.
    Endocrinology; 1989 May 25; 124(5):2456-63. PubMed ID: 2539981
    [Abstract] [Full Text] [Related]

  • 40. Structurally diverse N-terminal peptides of parathyroid hormone (PTH) and PTH-related peptide (PTHRP) inhibit the Na+/H+ exchanger NHE3 isoform by binding to the PTH/PTHRP receptor type I and activating distinct signaling pathways.
    Azarani A, Goltzman D, Orlowski J.
    J Biol Chem; 1996 Jun 21; 271(25):14931-6. PubMed ID: 8663042
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.